| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Cholestatic liver diseases: new strategies for prevention and treatment ofhepatobiliary and cholestatic diseases |
van de Meeberg, P.C.;Wolfhagen, F.H.J.;van Erpecum, K.J.;van Berge Henegouwen, G.P.; |
The Netherlands Journal of Medicine |
1995-07-01 |
查看 |
| Clinical aspects of aorto-enteric fistula with special emphasis on thevalue of endoscopy. |
Leenhouts, P.A.;Eikelboom, B.C.;Stuifbergen, A.B.;van Berge Henegouwen, D.P.;van Berge Henegouwen, G.P.;van Erpecum, K.J.; |
The Netherlands Journal of Medicine |
1995-08-01 |
查看 |
| Effects of simvastatin and cholestyramine on bile lipid composition andgallbladder motility in patients with hypercholesterolaemia. |
Smit, J.W.A.;van Erpecum, K.J.;Portincasa, P.;van Berge Henegouwen, G.P.; |
The Netherlands Journal of Medicine |
1995-08-01 |
查看 |
| Nucleation behaviour of various cholesterol (xol) crystals in bile fromgallstone patients. |
Portincasa, P.;van Erpecum, K.J.;Jansen, A.;Renooij, W.;Gadellaa, M.;van Berge Henegouwen, G.P.; |
The Netherlands Journal of Medicine |
1995-08-01 |
查看 |
| Bile salt hydrophobicity and phosphatidylcholine acyl chain composition invesicles and mixed micelles from model and human gallbladder bile. |
Renooij, W.;van Erpecum, K.J.;van de Heijning, B.J.M.;van Gaal, P.J.;van den Broek, A.M.W.C.;Portincasa, P.;van Berge Henegouwen, G.P.; |
The Netherlands Journal of Medicine |
1995-08-01 |
查看 |
| Gallbladder (GB) motility is important for gallstone (GS) clearance andrecurrence after extracorporeal shock-wave lithotripsy (ESWL). |
van Erpecum, K.J.;van de Meeberg, P.;van Berge Henegouwen, G.P.;Portincasa, P.; |
The Netherlands Journal of Medicine |
1995-08-01 |
查看 |
| Ulcerative colitis (UC) and primary sclerosing cholangitis (PSC): potentialinfluence of smoking behaviour and appendectomy. |
Smits, J.H.M.;Linn, F.H.H.;van de Meeberg, P.;Wolfhagen, F.H.J.;van Berge-Henegouwen, G.P.;van Erpecum, K.J.; |
The Netherlands Journal of Medicine |
1995-08-01 |
查看 |
| Single dose or multiple doses of ursodeoxycholic acid (UDCA) are equallyeffective in the treatment of primary sclerosing cholangitis (PSC) andprimary biliary cirrhosis (PBC). |
van de Meeberg, P.C.;Wolfhagen, F.H.J.;van Erpecum, K.J.;Salemans, J.M.J.I.;Schalm, S.W.;van Berge-Henegouwen, G.P.; |
The Netherlands Journal of Medicine |
1995-08-01 |
查看 |
| Apolipoprotein (Apo) E4 genotype is associated with increased risk ofcholesterol (XOL) gallstone recurrence after shock-wave lithotripsy (ESWL). |
Portincasa, P.;van Erpecum, K.J.;van de Meeberg, P.;Dallinga-Thie, G.M.;de Bruin, T.W.A.;van Berge-Henegouwen, G.P.; |
The Netherlands Journal of Medicine |
1996-01-01 |
查看 |
| Ursodeoxycholic acid (UDCA) reduces protein levels and theirnucleation-promoting activity in gallbladder bile of cholesterol stonepatients. |
van Erpecum, K.J.;Portincasa, P.;Eckhardt, E.;van Berge-Henegouwen, G.P.;Groen, A.K.; |
The Netherlands Journal of Medicine |
1996-01-01 |
查看 |
| Gallbladder (GB) emptying in vivo and contractility in vitro of gallstonepatients on ursodeoxycholic acid (UDCA). |
van de Meeberg, P.C.;Portincasa, P.;van de Heijning, B.J.M.;van Erpecum, K.J.;Akkermans, L.M.A.;van Berge Henegouwen, G.; |
The Netherlands Journal of Medicine |
1996-01-01 |
查看 |
|
|
